Andrea Newkirk
Stock Analyst at Goldman Sachs
(3.04)
# 1,357
Out of 5,138 analysts
4
Total ratings
100%
Success rate
118.07%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $17.47 | +8.76% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $123.27 | -40.78% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $31.22 | +37.73% | 1 | Jul 15, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $17.47
Upside: +8.76%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $123.27
Upside: -40.78%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $31.22
Upside: +37.73%